
NMPA approves novel globally trialled therapy before US, Japan, Europe
What China’s first approval ahead of major regulators means for biopharma strategy, timelines, and competitive pressure.

Curating from trusted global sources…
34 briefings · “eu”

What China’s first approval ahead of major regulators means for biopharma strategy, timelines, and competitive pressure.

Secondary-market bidders are paying premium prices for access to Elon Musk's AI and robotics bets, even as valuations stay murky.

NeuralMesh 6 turns NAND flash into GPU memory so teams stop redoing attention work every chat turn.
New Florida International University simulations suggest mergers are not the universal kill switch for star formation.

A White House report called the museum insufficiently patriotic. Now lawmakers are putting the museum director on the hot seat.

A new nonprofit aims to streamline gene therapy for hard-to-fund conditions, reshaping incentives across biotech and regulators.
A glass capillary frozen into a fiber lets photonic systems trade energy waste for tighter light-sound linkage.
New research suggests primates share key geometric intuition, forcing rethink across neuroscience, AI, and education priorities.

Open-weight AI is not open-source economics, and that mismatch is crushing model makers while powering cloud operators.

The company claims Lilly used “intentionally selected outdated studies” to make Zepbound and Mounjaro look better.

French lawmakers approve the senator by a narrow margin, sparking fears the rights watchdog will miss its mission.

Behind Nate’s buried-alive scene, Elordi details the real physical torture that producers asked him to endure.